Market Tracker

05/24 3:43am ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

56.07
Delayed Data
As of May 23
 +0.96 / +1.74%
Today’s Change
49.96
Today|||52-Week Range
140.00
-40.44%
Year-to-Date
Drawing Biopharma Concepts With A Crayon
May 23 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close55.11
Today’s open55.12
Day’s range54.53 - 56.90
Volume612,309
Average volume (3 months)1,022,344
Market cap$4.7B
Dividend yield--
Data as of 05/23/2016

Growth & Valuation

Earnings growth (last year)+28.87%
Earnings growth (this year)-43.45%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-18.72%
P/E ratioNM
Price/Sales192.40
Price/Book3.71

Competitors

 Today’s
change
Today’s
% change
IONSIonis Pharmaceutical...+0.49+1.46%
CRLCharles River Labora...-0.10-0.12%
ICLRICON PLC+0.16+0.24%
PRXLPAREXEL Internationa...-0.06-0.10%
Data as of 4:01pm ET, 05/23/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$1.21
Annual revenue (last year)$41.1M
Annual profit (last year)-$290.1M
Net profit margin-705.83%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts